Comparative Characterization of the Human and Mouse Third Ventricle Germinal ZonesDAHIYA, Sonika; DA YONG LEE; GUTMANN, David H et al.Journal of neuropathology and experimental neurology. 2011, Vol 70, Num 7, pp 622-633, issn 0022-3069, 12 p.Article

Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growthDAGINAKATTE, Girish C; GUTMANN, David H.Human molecular genetics (Print). 2007, Vol 16, Num 9, pp 1098-1112, issn 0964-6906, 15 p.Article

Tumorigenesis in the Brain : Location, location, locationGILBERTSON, Richard J; GUTMANN, David H.Cancer research (Baltimore). 2007, Vol 67, Num 12, pp 5579-5582, issn 0008-5472, 4 p.Article

International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosisFERNER, Rosalie E; GUTMANN, David H.Cancer research (Baltimore). 2002, Vol 62, Num 5, pp 1573-1577, issn 0008-5472Article

Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic miceLIJUN WANG; GUTMANN, David H; ROOS, Raymond P et al.Human molecular genetics (Print). 2011, Vol 20, Num 2, pp 286-293, issn 0964-6906, 8 p.Article

Neurofibromatosis 1 : From lab bench to clinicWARD, Beth Ann; GUTMANN, David H.Pediatric neurology. 2005, Vol 32, Num 4, pp 221-228, issn 0887-8994, 8 p.Article

Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene functionSURACE, Ezequiel I; HAIPEK, Carrie A; GUTMANN, David H et al.Oncogene (Basingstoke). 2004, Vol 23, Num 2, pp 580-587, issn 0950-9232, 8 p.Article

Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomasJUN LI; PERRY, Arie; JAMES, C. David et al.Neurology. 2001, Vol 56, Num 7, pp 885-890, issn 0028-3878Article

Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytesDASGUPTA, Biplab; WEN LI; PERRY, Arie et al.Cancer research (Baltimore). 2005, Vol 65, Num 1, pp 236-245, issn 0008-5472, 10 p.Article

Functional analysis of neurofibromatosis 2 (NF2) missense mutationsGUTMANN, David H; HIRBE, Angela C; HAIPEK, Carrie A et al.Human molecular genetics (Print). 2001, Vol 10, Num 14, pp 1519-1529, issn 0964-6906Article

Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant miceBROWN, Jacquelyn A; EMNETT, Ryan J; WHITE, Crystal R et al.Human molecular genetics (Print). 2010, Vol 19, Num 22, pp 4515-4528, issn 0964-6906, 14 p.Article

Increased c-Jun-NH₂-Kinase Signaling in Neurofibromatosis-1 Heterozygous Microglia Drives Microglia Activation and Promotes Optic Glioma ProliferationDAGINAKATTE, Girish C; GIANINO, Scott M; ZHAO, Nina W et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 24, pp 10358-10366, issn 0008-5472, 9 p.Article

Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissuesMILLER, Shyra J; RANGWALA, Fatima; MAUTNER, Victor et al.Cancer research (Baltimore). 2006, Vol 66, Num 5, pp 2584-2591, issn 0008-5472, 8 p.Article

RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytomaSHARMA, Mukesh K; ZEHNBAUER, Barbara A; WATSON, Mark A et al.Neurology. 2005, Vol 65, Num 8, pp 1335-1336, issn 0028-3878, 2 p.Article

Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nfl brain heterozygosityBAJENARU, M. Livia; HERNANDEZ, M. Rosario; PERRY, Arie et al.Cancer research (Baltimore). 2003, Vol 63, Num 24, pp 8573-8577, issn 0008-5472, 5 p.Article

Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2CHAN, Chi-Chao; KOCH, Christian A; KAISER-KUPFER, Muriel I et al.Journal of pathology. 2002, Vol 198, Num 1, pp 14-20, issn 0022-3417Article

Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cellsUHLMANN, Erik J; APICELLI, Anthony J; BALDWIN, Rebecca L et al.Oncogene (Basingstoke). 2002, Vol 21, Num 25, pp 4050-4059, issn 0950-9232, 10 p.Article

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: A clinicopathologic study of 53 casesPERRY, Arie; GIANNINI, Caterina; RAGHAVAN, Ravi et al.Journal of neuropathology and experimental neurology. 2001, Vol 60, Num 10, pp 994-1003, issn 0022-3069Article

Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomasHAO DING; RONCARI, Luba; SHANNON, Patrick et al.Cancer research (Baltimore). 2001, Vol 61, Num 9, pp 3826-3836, issn 0008-5472Conference Paper

Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma : A correlative immunohistochemical study of 175 casesPERRY, Arie; CAI, Dan X; SCHEITHAUER, Bernd W et al.Journal of neuropathology and experimental neurology. 2000, Vol 59, Num 10, pp 872-879, issn 0022-3069Article

Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathwaySHUANG WEI; MIN XIONG; ZHAN, Da-Qian et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 3, pp 538-547, issn 0143-3334, 10 p.Article

The Neurofibromatosis Type 1 Tumor Suppressor Controls Cell Growth by Regulating Signal Transducer and Activator of Transcription-3 Activity In vitro and In vivoBANERJEE, Sutapa; BYRD, Jonathan N; GIANINO, Scott M et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 4, pp 1356-1366, issn 0008-5472, 11 p.Article

Optic Nerve Dysfunction in a Mouse Model of Neurofibromatosis-1 Optic GliomaHEGEDUS, Balazs; HUGHES, Frank W; GARBOW, Joel R et al.Journal of neuropathology and experimental neurology. 2009, Vol 68, Num 5, pp 542-551, issn 0022-3069, 10 p.Article

Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14qll.2 in primary glioblastomaTEPEL, Martin; ROERIG, Peter; WOLTER, Marietta et al.International journal of cancer. 2008, Vol 123, Num 9, pp 2080-2086, issn 0020-7136, 7 p.Article

Page / 3